Review ARTICLE

Front. Public Health, 16 June 2014 | doi: 10.3389/fpubh.2014.00046

ADHD and adolescent athletes

  • 1Child and Adolescent Psychiatry, Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, USA
  • 2Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, USA
  • 3Clinical Research, Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, USA

Attention-deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that affects the child and adolescent population. It is characterized by impairment in attention/concentration, hyperactivity, and impulsivity, all of which can impact performance of athletes. ADHD treatment within the athletic population is a unique challenge. The research in this field has been relatively limited. The National Collegiate Athletic Association and International Olympic Committee both regulate the use of psychostimulants for treatment of ADHD due to their performance-enhancing effects. In this article, authors have discussed the screening methods, pharmacological treatment, side effects, and behavioral approaches for the treatment of ADHD in adolescent athletes.

Keywords: attention-deficit hyperactivity disorder, adolescents, athletes, sports, stimulants, pharmacotherapies

Citation: Nazeer A, Mansour M and Gross KA (2014) ADHD and adolescent athletes. Front. Public Health 2:46. doi: 10.3389/fpubh.2014.00046

Received: 25 November 2013; Accepted: 02 May 2014;
Published online: 17 June 2014.

Edited by:

Udo Rolle, Goethe University Frankfurt am Main, Germany

Reviewed by:

Mladen Jasic, General Hospital Pula, Croatia
Daniel Rossignol, Rossignol Medical Center, USA

Copyright: © 2014 Nazeer, Mansour and Gross. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ahsan Nazeer, Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine, 1717 Shaffer Road, Suite 010, Kalamazoo, MI 49048, USA e-mail: ahsan.nazeer@med.wmich.edu

Back to top